| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 96 | 2026 | 322 | 14.860 |
Why?
|
| Pesticides | 17 | 2022 | 58 | 6.070 |
Why?
|
| Occupational Diseases | 29 | 2022 | 266 | 4.180 |
Why?
|
| Air Pollutants, Occupational | 39 | 2019 | 75 | 3.900 |
Why?
|
| Thailand | 29 | 2022 | 91 | 3.530 |
Why?
|
| Farmers | 14 | 2022 | 20 | 3.480 |
Why?
|
| Agriculture | 12 | 2022 | 31 | 3.220 |
Why?
|
| Isocyanates | 21 | 2022 | 47 | 3.120 |
Why?
|
| Agricultural Workers' Diseases | 6 | 2019 | 7 | 2.820 |
Why?
|
| Inhalation Exposure | 16 | 2020 | 54 | 2.250 |
Why?
|
| Oryza | 4 | 2022 | 36 | 2.100 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 155 | 1.860 |
Why?
|
| Polyurethanes | 7 | 2022 | 29 | 1.820 |
Why?
|
| Dust | 13 | 2019 | 42 | 1.820 |
Why?
|
| Organic Agriculture | 3 | 2019 | 3 | 1.770 |
Why?
|
| Herbicides | 3 | 2021 | 20 | 1.730 |
Why?
|
| Respiratory Tract Diseases | 11 | 2026 | 40 | 1.720 |
Why?
|
| Maternal Exposure | 4 | 2018 | 43 | 1.660 |
Why?
|
| Protective Clothing | 7 | 2024 | 29 | 1.610 |
Why?
|
| Workplace | 13 | 2020 | 177 | 1.430 |
Why?
|
| Musculoskeletal Diseases | 4 | 2022 | 105 | 1.430 |
Why?
|
| Occupational Health | 16 | 2017 | 195 | 1.420 |
Why?
|
| Veterans | 6 | 2025 | 761 | 1.300 |
Why?
|
| Automobiles | 25 | 2009 | 66 | 1.270 |
Why?
|
| Paraquat | 4 | 2021 | 13 | 1.250 |
Why?
|
| Humans | 140 | 2026 | 65490 | 1.240 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2020 | 146 | 1.200 |
Why?
|
| Materials Testing | 3 | 2019 | 88 | 1.140 |
Why?
|
| Employment | 3 | 2021 | 132 | 1.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2018 | 155 | 1.100 |
Why?
|
| Benzhydryl Compounds | 6 | 2024 | 61 | 1.070 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 870 | 1.060 |
Why?
|
| Housing | 3 | 2018 | 74 | 1.040 |
Why?
|
| Industry | 10 | 2015 | 59 | 1.020 |
Why?
|
| Asthma | 10 | 2019 | 485 | 1.000 |
Why?
|
| Nanotubes, Carbon | 2 | 2016 | 19 | 0.940 |
Why?
|
| Cross-Sectional Studies | 21 | 2022 | 2724 | 0.940 |
Why?
|
| Nanofibers | 2 | 2016 | 20 | 0.930 |
Why?
|
| Incineration | 1 | 2025 | 2 | 0.910 |
Why?
|
| Fluorocarbons | 3 | 2023 | 52 | 0.890 |
Why?
|
| Environmental Exposure | 12 | 2020 | 226 | 0.880 |
Why?
|
| Dermatitis, Contact | 2 | 2024 | 12 | 0.860 |
Why?
|
| Drinking Water | 2 | 2022 | 21 | 0.860 |
Why?
|
| Accidents, Occupational | 5 | 2021 | 49 | 0.850 |
Why?
|
| Nanoparticles | 7 | 2017 | 547 | 0.850 |
Why?
|
| Adult | 46 | 2025 | 17465 | 0.840 |
Why?
|
| Pesticide Residues | 2 | 2022 | 7 | 0.840 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 11 | 0.820 |
Why?
|
| Occupations | 5 | 2021 | 52 | 0.820 |
Why?
|
| Air Pollution, Indoor | 10 | 2017 | 38 | 0.810 |
Why?
|
| Noise, Occupational | 4 | 2019 | 13 | 0.810 |
Why?
|
| Male | 54 | 2025 | 31202 | 0.810 |
Why?
|
| Caprylates | 3 | 2023 | 15 | 0.790 |
Why?
|
| Helianthus | 1 | 2022 | 6 | 0.760 |
Why?
|
| Young Adult | 13 | 2025 | 4838 | 0.750 |
Why?
|
| Silicon Dioxide | 4 | 2019 | 63 | 0.750 |
Why?
|
| Occupational Injuries | 3 | 2021 | 38 | 0.730 |
Why?
|
| Female | 48 | 2025 | 34208 | 0.720 |
Why?
|
| Afghan Campaign 2001- | 5 | 2025 | 66 | 0.720 |
Why?
|
| Iraq War, 2003-2011 | 5 | 2025 | 61 | 0.720 |
Why?
|
| Cannabis | 1 | 2022 | 54 | 0.710 |
Why?
|
| Fluorosis, Dental | 1 | 2021 | 1 | 0.710 |
Why?
|
| Groundwater | 1 | 2021 | 5 | 0.710 |
Why?
|
| Middle Aged | 34 | 2025 | 18390 | 0.700 |
Why?
|
| Organophosphorus Compounds | 2 | 2020 | 33 | 0.670 |
Why?
|
| Surveys and Questionnaires | 14 | 2022 | 2776 | 0.670 |
Why?
|
| Risk Factors | 17 | 2022 | 5459 | 0.660 |
Why?
|
| Noncommunicable Diseases | 1 | 2021 | 18 | 0.660 |
Why?
|
| Saccharum | 1 | 2020 | 1 | 0.650 |
Why?
|
| Heat Stress Disorders | 1 | 2020 | 9 | 0.650 |
Why?
|
| Agrochemicals | 1 | 2020 | 4 | 0.640 |
Why?
|
| Triiodothyronine | 2 | 2021 | 30 | 0.640 |
Why?
|
| Thyrotropin | 2 | 2021 | 35 | 0.640 |
Why?
|
| Blood Glucose | 2 | 2020 | 502 | 0.640 |
Why?
|
| Thyroxine | 2 | 2021 | 55 | 0.630 |
Why?
|
| Biomarkers | 4 | 2020 | 1484 | 0.630 |
Why?
|
| Construction Industry | 3 | 2020 | 20 | 0.620 |
Why?
|
| Prevalence | 6 | 2022 | 1451 | 0.620 |
Why?
|
| Pregnancy | 8 | 2018 | 2392 | 0.610 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2019 | 6 | 0.600 |
Why?
|
| Cohort Studies | 13 | 2025 | 2633 | 0.600 |
Why?
|
| Metallurgy | 10 | 2004 | 16 | 0.590 |
Why?
|
| Health Status Disparities | 1 | 2021 | 147 | 0.590 |
Why?
|
| Recycling | 2 | 2016 | 4 | 0.590 |
Why?
|
| Body Mass Index | 2 | 2020 | 899 | 0.580 |
Why?
|
| Child Development | 2 | 2017 | 87 | 0.570 |
Why?
|
| Acetamides | 1 | 2018 | 17 | 0.570 |
Why?
|
| Hearing Loss | 1 | 2019 | 55 | 0.560 |
Why?
|
| Meconium | 1 | 2018 | 3 | 0.560 |
Why?
|
| Infant, Newborn | 3 | 2018 | 1431 | 0.560 |
Why?
|
| Nanostructures | 2 | 2010 | 187 | 0.550 |
Why?
|
| Indonesia | 4 | 2022 | 10 | 0.550 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 59 | 0.550 |
Why?
|
| Chemical Industry | 2 | 2012 | 8 | 0.540 |
Why?
|
| Blood Pressure | 1 | 2020 | 535 | 0.520 |
Why?
|
| Safety | 2 | 2015 | 142 | 0.520 |
Why?
|
| Home Care Services | 1 | 2018 | 104 | 0.520 |
Why?
|
| Poverty | 2 | 2019 | 307 | 0.510 |
Why?
|
| Postpartum Period | 2 | 2018 | 188 | 0.500 |
Why?
|
| Glycine | 1 | 2017 | 48 | 0.500 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 108 | 0.490 |
Why?
|
| Longitudinal Studies | 6 | 2021 | 1285 | 0.480 |
Why?
|
| Hypertension | 1 | 2022 | 616 | 0.480 |
Why?
|
| Health Care Sector | 1 | 2016 | 20 | 0.470 |
Why?
|
| Polypropylenes | 1 | 2015 | 7 | 0.470 |
Why?
|
| Paint | 9 | 2020 | 23 | 0.450 |
Why?
|
| Military Personnel | 4 | 2026 | 110 | 0.440 |
Why?
|
| Borates | 7 | 1998 | 7 | 0.430 |
Why?
|
| United States | 21 | 2026 | 8148 | 0.420 |
Why?
|
| Quartz | 3 | 2002 | 8 | 0.420 |
Why?
|
| Gloves, Protective | 3 | 2019 | 7 | 0.420 |
Why?
|
| Case-Control Studies | 11 | 2021 | 1143 | 0.400 |
Why?
|
| Skin | 6 | 2020 | 428 | 0.390 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 4 | 2019 | 39 | 0.390 |
Why?
|
| Cognition | 1 | 2017 | 510 | 0.390 |
Why?
|
| Hevea | 1 | 2013 | 1 | 0.390 |
Why?
|
| Regression Analysis | 10 | 2018 | 498 | 0.380 |
Why?
|
| Wood | 1 | 2013 | 11 | 0.380 |
Why?
|
| Ergonomics | 3 | 2022 | 79 | 0.370 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 389 | 0.360 |
Why?
|
| Emergency Responders | 1 | 2011 | 9 | 0.350 |
Why?
|
| Rescue Work | 1 | 2011 | 14 | 0.350 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2011 | 21 | 0.350 |
Why?
|
| Nitriles | 2 | 2024 | 82 | 0.350 |
Why?
|
| Copying Processes | 3 | 2017 | 10 | 0.340 |
Why?
|
| Oxidative Stress | 2 | 2013 | 321 | 0.340 |
Why?
|
| Disaster Planning | 1 | 2011 | 57 | 0.330 |
Why?
|
| Fluorides | 2 | 2021 | 29 | 0.330 |
Why?
|
| Environmental Pollutants | 3 | 2020 | 97 | 0.330 |
Why?
|
| Particulate Matter | 2 | 2026 | 72 | 0.330 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 154 | 0.330 |
Why?
|
| Railroads | 10 | 1992 | 11 | 0.320 |
Why?
|
| Child | 5 | 2022 | 4623 | 0.310 |
Why?
|
| Hot Temperature | 2 | 2020 | 147 | 0.310 |
Why?
|
| Construction Materials | 4 | 2009 | 16 | 0.310 |
Why?
|
| Urban Population | 3 | 2018 | 200 | 0.310 |
Why?
|
| Particle Size | 7 | 2016 | 431 | 0.310 |
Why?
|
| Semiconductors | 7 | 2000 | 14 | 0.300 |
Why?
|
| Nanotechnology | 1 | 2010 | 139 | 0.300 |
Why?
|
| Organophosphates | 4 | 2020 | 14 | 0.300 |
Why?
|
| Skin Absorption | 5 | 2016 | 16 | 0.280 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2008 | 14 | 0.280 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2008 | 38 | 0.270 |
Why?
|
| Massachusetts | 6 | 2018 | 2153 | 0.260 |
Why?
|
| Phenols | 1 | 2008 | 77 | 0.260 |
Why?
|
| Hazardous Substances | 3 | 2016 | 16 | 0.250 |
Why?
|
| Air Pollutants | 4 | 2017 | 100 | 0.250 |
Why?
|
| Irritants | 3 | 1998 | 5 | 0.250 |
Why?
|
| Vehicle Emissions | 4 | 2002 | 23 | 0.250 |
Why?
|
| Lead | 4 | 2014 | 46 | 0.240 |
Why?
|
| Metals | 7 | 2020 | 65 | 0.240 |
Why?
|
| Respiration Disorders | 3 | 1997 | 26 | 0.230 |
Why?
|
| Adolescent | 4 | 2021 | 6333 | 0.220 |
Why?
|
| Motor Vehicles | 1 | 2004 | 32 | 0.210 |
Why?
|
| Solvents | 3 | 2004 | 60 | 0.210 |
Why?
|
| Latex | 1 | 2024 | 5 | 0.210 |
Why?
|
| Epoxy Resins | 1 | 2024 | 4 | 0.210 |
Why?
|
| Alkanesulfonic Acids | 1 | 2023 | 10 | 0.200 |
Why?
|
| Afghanistan | 1 | 2023 | 14 | 0.190 |
Why?
|
| Industrial Oils | 3 | 1997 | 5 | 0.190 |
Why?
|
| Ventilation | 5 | 2014 | 7 | 0.190 |
Why?
|
| Aerosols | 5 | 2003 | 46 | 0.190 |
Why?
|
| Carbaryl | 1 | 2022 | 1 | 0.190 |
Why?
|
| Hydroponics | 1 | 2022 | 3 | 0.190 |
Why?
|
| Naphthols | 1 | 2022 | 3 | 0.190 |
Why?
|
| Iraq | 1 | 2023 | 18 | 0.190 |
Why?
|
| Filtration | 1 | 2002 | 19 | 0.190 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 52 | 0.190 |
Why?
|
| West Virginia | 2 | 2012 | 6 | 0.190 |
Why?
|
| Logistic Models | 6 | 2021 | 1273 | 0.190 |
Why?
|
| Plants | 1 | 2022 | 50 | 0.190 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 250 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2021 | 887 | 0.180 |
Why?
|
| Citrus sinensis | 1 | 2021 | 11 | 0.180 |
Why?
|
| Infant | 2 | 2017 | 1704 | 0.180 |
Why?
|
| Forced Expiratory Volume | 8 | 2013 | 213 | 0.180 |
Why?
|
| Petroleum | 5 | 1994 | 10 | 0.180 |
Why?
|
| Algorithms | 3 | 2008 | 1050 | 0.170 |
Why?
|
| Farms | 1 | 2021 | 4 | 0.170 |
Why?
|
| Quality of Life | 2 | 2019 | 1263 | 0.170 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 66 | 0.170 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 59 | 0.170 |
Why?
|
| Air Microbiology | 2 | 2000 | 11 | 0.170 |
Why?
|
| Aged | 8 | 2022 | 15058 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2021 | 83 | 0.170 |
Why?
|
| Humidity | 1 | 2020 | 12 | 0.160 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 86 | 0.160 |
Why?
|
| Saliva | 1 | 2021 | 100 | 0.160 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2025 | 405 | 0.160 |
Why?
|
| Cytokines | 3 | 2013 | 955 | 0.160 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 38 | 0.160 |
Why?
|
| Proteinuria | 1 | 2020 | 41 | 0.160 |
Why?
|
| Waist Circumference | 1 | 2020 | 47 | 0.160 |
Why?
|
| Creatinine | 1 | 2020 | 136 | 0.160 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2017 | 40 | 0.150 |
Why?
|
| Hydrocortisone | 1 | 2021 | 192 | 0.150 |
Why?
|
| Workers' Compensation | 2 | 2021 | 71 | 0.150 |
Why?
|
| Textiles | 1 | 2019 | 10 | 0.150 |
Why?
|
| Environmental Restoration and Remediation | 1 | 2019 | 5 | 0.150 |
Why?
|
| Permeability | 1 | 2019 | 51 | 0.150 |
Why?
|
| Health | 1 | 2019 | 30 | 0.150 |
Why?
|
| Skin Tests | 1 | 2018 | 18 | 0.140 |
Why?
|
| Body Weights and Measures | 1 | 2018 | 33 | 0.140 |
Why?
|
| Nose | 1 | 1998 | 27 | 0.140 |
Why?
|
| Public Housing | 1 | 2018 | 13 | 0.140 |
Why?
|
| Public Health | 1 | 2020 | 187 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2016 | 139 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2020 | 210 | 0.140 |
Why?
|
| Vegetables | 1 | 2018 | 67 | 0.140 |
Why?
|
| Mortality | 3 | 2012 | 162 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 362 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2025 | 822 | 0.130 |
Why?
|
| Boston | 5 | 2009 | 260 | 0.130 |
Why?
|
| Fetal Blood | 1 | 2017 | 73 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 54 | 0.120 |
Why?
|
| Polycarboxylate Cement | 1 | 2016 | 4 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2018 | 300 | 0.120 |
Why?
|
| Lipids | 1 | 2018 | 328 | 0.120 |
Why?
|
| Transportation | 3 | 2011 | 32 | 0.120 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 27 | 0.120 |
Why?
|
| Mineral Oil | 2 | 2000 | 5 | 0.120 |
Why?
|
| Carbon | 3 | 2015 | 52 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2018 | 1021 | 0.120 |
Why?
|
| Reproduction | 2 | 2008 | 99 | 0.120 |
Why?
|
| Research Design | 4 | 2010 | 590 | 0.110 |
Why?
|
| Women, Working | 1 | 2015 | 10 | 0.110 |
Why?
|
| Vital Capacity | 3 | 2013 | 123 | 0.110 |
Why?
|
| State Medicine | 1 | 2015 | 12 | 0.110 |
Why?
|
| Public Assistance | 1 | 2015 | 9 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2016 | 86 | 0.110 |
Why?
|
| Health Behavior | 1 | 2018 | 485 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 1995 | 142 | 0.110 |
Why?
|
| Mesothelioma | 2 | 2012 | 28 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2016 | 223 | 0.110 |
Why?
|
| Inservice Training | 1 | 2015 | 85 | 0.110 |
Why?
|
| DNA Damage | 2 | 2013 | 298 | 0.110 |
Why?
|
| Hypersensitivity | 2 | 2004 | 73 | 0.110 |
Why?
|
| Mutagens | 2 | 1992 | 17 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1994 | 49 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2019 | 2111 | 0.100 |
Why?
|
| Electronics | 1 | 2014 | 33 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 769 | 0.100 |
Why?
|
| Respiratory System | 1 | 1994 | 46 | 0.100 |
Why?
|
| Printing | 1 | 2013 | 21 | 0.100 |
Why?
|
| Fuel Oils | 2 | 1990 | 5 | 0.100 |
Why?
|
| Respiratory Protective Devices | 3 | 2010 | 12 | 0.100 |
Why?
|
| Intelligence | 1 | 2013 | 51 | 0.100 |
Why?
|
| Dermatitis | 2 | 2006 | 28 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 1710 | 0.100 |
Why?
|
| Interior Design and Furnishings | 1 | 2013 | 3 | 0.100 |
Why?
|
| Nervous System | 1 | 2013 | 71 | 0.100 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2013 | 7 | 0.100 |
Why?
|
| Laboratories | 2 | 2014 | 27 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6936 | 0.100 |
Why?
|
| Posture | 3 | 2009 | 128 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2018 | 2066 | 0.090 |
Why?
|
| Models, Theoretical | 3 | 2012 | 274 | 0.090 |
Why?
|
| Nasal Lavage Fluid | 1 | 2012 | 7 | 0.090 |
Why?
|
| Protective Devices | 2 | 2010 | 12 | 0.090 |
Why?
|
| Deoxyguanosine | 1 | 2012 | 19 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 318 | 0.090 |
Why?
|
| Health Education | 1 | 2014 | 190 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2016 | 475 | 0.090 |
Why?
|
| Polytetrafluoroethylene | 1 | 2012 | 17 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 707 | 0.090 |
Why?
|
| Risk | 3 | 2011 | 374 | 0.090 |
Why?
|
| Social Support | 1 | 2015 | 393 | 0.090 |
Why?
|
| Health Care Costs | 1 | 2014 | 224 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2017 | 515 | 0.090 |
Why?
|
| Volunteers | 1 | 2011 | 17 | 0.090 |
Why?
|
| Lung Neoplasms | 4 | 1997 | 708 | 0.090 |
Why?
|
| New York City | 1 | 2011 | 96 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 5649 | 0.090 |
Why?
|
| New England | 3 | 2020 | 271 | 0.090 |
Why?
|
| Exercise | 1 | 2018 | 967 | 0.090 |
Why?
|
| Apoptosis | 2 | 2013 | 1098 | 0.080 |
Why?
|
| Anemia, Aplastic | 1 | 2011 | 10 | 0.080 |
Why?
|
| Mass Casualty Incidents | 1 | 2011 | 32 | 0.080 |
Why?
|
| Metal Nanoparticles | 1 | 2014 | 191 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2012 | 178 | 0.080 |
Why?
|
| Personnel, Hospital | 1 | 2011 | 43 | 0.080 |
Why?
|
| Oxides | 1 | 2010 | 36 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 175 | 0.080 |
Why?
|
| Risk Management | 1 | 2010 | 37 | 0.080 |
Why?
|
| Triazines | 3 | 2006 | 22 | 0.080 |
Why?
|
| Education | 1 | 2010 | 66 | 0.080 |
Why?
|
| Ethanolamines | 3 | 2003 | 18 | 0.080 |
Why?
|
| Nitrogen Dioxide | 1 | 1989 | 9 | 0.080 |
Why?
|
| Paintings | 1 | 2009 | 2 | 0.070 |
Why?
|
| Health Promotion | 1 | 2014 | 523 | 0.070 |
Why?
|
| Knee Injuries | 1 | 2009 | 49 | 0.070 |
Why?
|
| Epidemiologic Methods | 3 | 1995 | 67 | 0.070 |
Why?
|
| Time Factors | 9 | 2013 | 3774 | 0.070 |
Why?
|
| Dermatitis, Occupational | 1 | 2008 | 4 | 0.070 |
Why?
|
| Nitrosamines | 3 | 2003 | 9 | 0.070 |
Why?
|
| Connecticut | 2 | 2006 | 90 | 0.070 |
Why?
|
| Sulfur | 3 | 1997 | 16 | 0.070 |
Why?
|
| Lumbosacral Region | 1 | 2007 | 21 | 0.070 |
Why?
|
| Spinal Cord Compression | 1 | 2007 | 30 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2000 | 309 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5809 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 555 | 0.060 |
Why?
|
| Epidemiologic Studies | 2 | 2004 | 34 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2008 | 371 | 0.060 |
Why?
|
| Analysis of Variance | 5 | 2005 | 606 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2005 | 755 | 0.060 |
Why?
|
| Cyanates | 2 | 2006 | 4 | 0.060 |
Why?
|
| Acute Disease | 4 | 1996 | 663 | 0.060 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2005 | 10 | 0.060 |
Why?
|
| Decontamination | 1 | 2005 | 12 | 0.060 |
Why?
|
| Detergents | 1 | 2005 | 35 | 0.060 |
Why?
|
| Polymers | 2 | 2006 | 331 | 0.060 |
Why?
|
| Cause of Death | 2 | 2025 | 221 | 0.060 |
Why?
|
| Mining | 1 | 2004 | 5 | 0.050 |
Why?
|
| Data Collection | 2 | 2004 | 384 | 0.050 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2004 | 3 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 46 | 0.050 |
Why?
|
| Carcinogens, Environmental | 3 | 1988 | 6 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2026 | 400 | 0.050 |
Why?
|
| Comet Assay | 2 | 2013 | 11 | 0.050 |
Why?
|
| Epidemiological Monitoring | 1 | 2003 | 32 | 0.050 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2003 | 18 | 0.050 |
Why?
|
| Morbidity | 1 | 2003 | 110 | 0.050 |
Why?
|
| Canada | 1 | 2003 | 157 | 0.050 |
Why?
|
| Lung | 2 | 2015 | 969 | 0.050 |
Why?
|
| Maintenance | 1 | 2002 | 4 | 0.050 |
Why?
|
| Michigan | 5 | 2005 | 44 | 0.050 |
Why?
|
| Peak Expiratory Flow Rate | 2 | 2001 | 10 | 0.050 |
Why?
|
| Efficiency | 1 | 2002 | 39 | 0.050 |
Why?
|
| Welding | 1 | 2002 | 4 | 0.050 |
Why?
|
| Sampling Studies | 2 | 2000 | 65 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 1172 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 308 | 0.050 |
Why?
|
| Staphylococcus | 1 | 2021 | 17 | 0.040 |
Why?
|
| Cell Survival | 2 | 2013 | 588 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 63 | 0.040 |
Why?
|
| Sneezing | 1 | 2001 | 2 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 139 | 0.040 |
Why?
|
| Fixatives | 1 | 2001 | 16 | 0.040 |
Why?
|
| Formaldehyde | 1 | 2001 | 33 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 206 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2021 | 81 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 465 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2000 | 58 | 0.040 |
Why?
|
| Gasoline | 2 | 1992 | 4 | 0.040 |
Why?
|
| Surface Properties | 2 | 2013 | 283 | 0.040 |
Why?
|
| Air Movements | 2 | 2014 | 3 | 0.040 |
Why?
|
| Equipment Design | 2 | 2014 | 371 | 0.040 |
Why?
|
| Dyspnea | 1 | 2001 | 120 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 26 | 0.040 |
Why?
|
| Cell Line | 2 | 2013 | 2024 | 0.040 |
Why?
|
| Assisted Living Facilities | 1 | 2019 | 12 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 857 | 0.040 |
Why?
|
| Cough | 1 | 2001 | 183 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 48 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 91 | 0.040 |
Why?
|
| Animals | 5 | 2008 | 21390 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 169 | 0.030 |
Why?
|
| Weather | 2 | 1988 | 10 | 0.030 |
Why?
|
| Bronchitis | 1 | 1997 | 30 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2020 | 415 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 1998 | 94 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 63 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 81 | 0.030 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 130 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 140 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1995 | 30 | 0.030 |
Why?
|
| Temperature | 1 | 2017 | 317 | 0.030 |
Why?
|
| Industrial Development | 1 | 2015 | 1 | 0.030 |
Why?
|
| Collective Bargaining | 1 | 2015 | 1 | 0.030 |
Why?
|
| Computer Systems | 1 | 2015 | 13 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 806 | 0.030 |
Why?
|
| Economic Recession | 1 | 2015 | 5 | 0.030 |
Why?
|
| Social Security | 1 | 2015 | 9 | 0.030 |
Why?
|
| Women's Rights | 1 | 2015 | 7 | 0.030 |
Why?
|
| Paper | 1 | 2015 | 13 | 0.030 |
Why?
|
| Asbestos | 4 | 1988 | 11 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 1995 | 267 | 0.030 |
Why?
|
| Titanium | 1 | 2015 | 59 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1994 | 34 | 0.030 |
Why?
|
| Polycyclic Compounds | 1 | 1994 | 2 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 1995 | 125 | 0.030 |
Why?
|
| Mutagenicity Tests | 2 | 1992 | 7 | 0.030 |
Why?
|
| Sulfur Hexafluoride | 1 | 2014 | 3 | 0.030 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2014 | 2 | 0.030 |
Why?
|
| Inorganic Chemicals | 1 | 2014 | 5 | 0.030 |
Why?
|
| Gases | 1 | 2014 | 19 | 0.030 |
Why?
|
| Manikins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Glass | 1 | 2014 | 23 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 1997 | 354 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2014 | 27 | 0.030 |
Why?
|
| Rural Health | 1 | 2013 | 16 | 0.020 |
Why?
|
| Respiratory Function Tests | 2 | 1997 | 195 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 20 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 51 | 0.020 |
Why?
|
| Solubility | 1 | 2013 | 192 | 0.020 |
Why?
|
| Health Status | 1 | 1995 | 447 | 0.020 |
Why?
|
| Mental Recall | 1 | 1993 | 95 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1993 | 99 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1992 | 37 | 0.020 |
Why?
|
| Nicotine | 2 | 1990 | 118 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 195 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 2 | 1992 | 55 | 0.020 |
Why?
|
| Focus Groups | 1 | 2013 | 328 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 663 | 0.020 |
Why?
|
| History, 20th Century | 2 | 1994 | 233 | 0.020 |
Why?
|
| Chronic Disease | 2 | 1997 | 742 | 0.020 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 11 | 0.020 |
Why?
|
| Carbamates | 1 | 2011 | 26 | 0.020 |
Why?
|
| Water | 2 | 2004 | 315 | 0.020 |
Why?
|
| Styrenes | 1 | 1990 | 3 | 0.020 |
Why?
|
| Neoplasms | 1 | 2001 | 1372 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 1990 | 6 | 0.020 |
Why?
|
| Thiocyanates | 1 | 1990 | 6 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 413 | 0.020 |
Why?
|
| Maximum Allowable Concentration | 2 | 2004 | 3 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 1990 | 24 | 0.020 |
Why?
|
| Cotinine | 1 | 1990 | 20 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 409 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1192 | 0.020 |
Why?
|
| Job Description | 1 | 2009 | 24 | 0.020 |
Why?
|
| Threshold Limit Values | 1 | 2009 | 2 | 0.020 |
Why?
|
| Lifting | 1 | 2009 | 6 | 0.020 |
Why?
|
| Skin Care | 1 | 2009 | 8 | 0.020 |
Why?
|
| Smoke | 1 | 1988 | 25 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 216 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1990 | 412 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2001 | 931 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2007 | 36 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2007 | 46 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 1038 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 101 | 0.020 |
Why?
|
| Colorimetry | 1 | 2007 | 26 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2007 | 115 | 0.020 |
Why?
|
| Smoking | 4 | 1994 | 863 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 164 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2007 | 293 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2006 | 86 | 0.010 |
Why?
|
| Ethanolamine | 1 | 2005 | 2 | 0.010 |
Why?
|
| Propylene Glycols | 1 | 2005 | 9 | 0.010 |
Why?
|
| Manufactured Materials | 1 | 2004 | 4 | 0.010 |
Why?
|
| Engineering | 1 | 2004 | 11 | 0.010 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 1984 | 2 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 79 | 0.010 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2004 | 9 | 0.010 |
Why?
|
| Government Agencies | 1 | 2004 | 11 | 0.010 |
Why?
|
| Kinetics | 1 | 2006 | 757 | 0.010 |
Why?
|
| Environmental Health | 1 | 2004 | 14 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2004 | 31 | 0.010 |
Why?
|
| Government Programs | 1 | 2004 | 19 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2004 | 315 | 0.010 |
Why?
|
| Facility Design and Construction | 1 | 2002 | 12 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2001 | 52 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2002 | 61 | 0.010 |
Why?
|
| Embalming | 1 | 2001 | 1 | 0.010 |
Why?
|
| Students, Health Occupations | 1 | 2001 | 1 | 0.010 |
Why?
|
| Acclimatization | 1 | 2001 | 11 | 0.010 |
Why?
|
| Registries | 1 | 2005 | 931 | 0.010 |
Why?
|
| Waste Disposal, Fluid | 1 | 2000 | 5 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 213 | 0.010 |
Why?
|
| Spirometry | 1 | 2001 | 114 | 0.010 |
Why?
|
| Anatomy | 1 | 2001 | 16 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 2001 | 46 | 0.010 |
Why?
|
| Cadaver | 1 | 2001 | 134 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 413 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 1996 | 0.010 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2000 | 9 | 0.010 |
Why?
|
| Incidence | 2 | 1992 | 1430 | 0.010 |
Why?
|
| Age Factors | 3 | 1987 | 1592 | 0.010 |
Why?
|
| Healthy Worker Effect | 1 | 1997 | 4 | 0.010 |
Why?
|
| Aluminum | 1 | 1997 | 13 | 0.010 |
Why?
|
| Oils | 1 | 1997 | 72 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1994 | 3325 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 744 | 0.010 |
Why?
|
| Chlorine | 1 | 1994 | 5 | 0.010 |
Why?
|
| Fats | 1 | 1994 | 20 | 0.010 |
Why?
|
| Styrene | 1 | 1990 | 2 | 0.010 |
Why?
|
| Mandelic Acids | 1 | 1990 | 2 | 0.010 |
Why?
|
| Demography | 1 | 1990 | 178 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 11143 | 0.000 |
Why?
|
| Psychomotor Performance | 1 | 1990 | 137 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 2492 | 0.000 |
Why?
|
| Learning | 1 | 1990 | 186 | 0.000 |
Why?
|
| Methylene Chloride | 1 | 1988 | 3 | 0.000 |
Why?
|
| Random Allocation | 1 | 1987 | 200 | 0.000 |
Why?
|